Milestone Pharmaceuticals Inc.
MIST · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $1 | $5 | $15 |
| % Growth | -100% | -80% | -66.7% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $1 | $5 | $15 |
| % Margin | – | 100% | 100% | 100% |
| R&D Expenses | $14 | $31 | $40 | $39 |
| G&A Expenses | $17 | $16 | $16 | $12 |
| SG&A Expenses | $28 | $31 | $25 | $19 |
| Sales & Mktg Exp. | $11 | $15 | $9 | $7 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $42 | $62 | $65 | $58 |
| Operating Income | -$42 | -$61 | -$60 | -$43 |
| % Margin | – | -6,109.8% | -1,192.8% | -287.2% |
| Other Income/Exp. Net | $1 | $1 | $1 | $0 |
| Pre-Tax Income | -$42 | -$60 | -$58 | -$43 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$42 | -$60 | -$58 | -$43 |
| % Margin | – | -5,968.5% | -1,167.8% | -285.7% |
| EPS | -0.67 | -1.39 | -1.35 | -1.02 |
| % Growth | 51.8% | -3% | -32.4% | – |
| EPS Diluted | -0.67 | -1.39 | -1.35 | -1.02 |
| Weighted Avg Shares Out | 62 | 43 | 42 | 42 |
| Weighted Avg Shares Out Dil | 62 | 43 | 42 | 42 |
| Supplemental Information | – | – | – | – |
| Interest Income | $4 | $4 | $1 | $0 |
| Interest Expense | -$4 | $3 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$38 | -$57 | -$58 | -$43 |
| % Margin | – | -5,703.9% | -1,166% | -286.5% |